Mission Bay Capital
Mission Bay Capital is a venture capital firm for early-stage investments.
Business Model:
Revenue: $12.7M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Mission Bay Capital Information
Geographic Data
Address: 1700 4th St
City: San Francisco
State: CA
Zip: 94143
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$85M
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Mission Bay Capital is a venture capital firm specializing in seed and early-stage investments.
Contact Phone:
+14152404970
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2016 | Tangible Science | Venture Round | 3M |
| 4/2020 | Nitrase Therapeutics | Series A | 38M |
| 9/2016 | Chrono Therapeutics | Series B | 47.6M |
| 12/2016 | Circle Pharma | Series A | 0 |
| 8/2019 | Glycomine | Series B | 0 |
| 10/2012 | Principia Biopharma | Series A | 12.5M |
| 1/2016 | Alector | Series D | 29.5M |
| 7/2010 | Calithera Biosciences | Series A | 40M |
| 3/2018 | Wildtype | Seed Round | 0 |
| 3/2023 | QurAlis | Series B | 0 |
| 7/2021 | Nobell Foods | Series B | 75M |
| 12/2015 | Effector Therapeutics | Series B | 40M |
| 12/2017 | Pionyr Immunotherapeutics | Series B | 0 |
| 6/2015 | Bolt Threads | Series B | 0 |
| 11/2014 | Bolt Threads | Series A | 0 |
| 12/2017 | Sound Agriculture | Series B | 12.3M |
| 9/2015 | Alector | Series C | 32M |
| 3/2015 | Caribou Biosciences | Series A | 0 |
| 6/2016 | Cell Design Labs | Equity | 34.4M |
| 4/2017 | LogicInk | Pre Seed Round | 1M |
| 4/2012 | Magnamosis | Seed Round | - |
| 4/2010 | Redwood Bioscience | Seed Round | 300k |
| 3/2015 | Tangible Science | Angel Round | 1M |
| 5/2016 | ViewPoint Therapeutics | Series A | 0 |
| 9/2014 | Zephyrus Biosciences | Seed Round | 1.5M |
| 5/2016 | Caribou Biosciences | Series B | 30M |
| 9/2014 | Circle Pharma | Seed Round | - |
| 7/2018 | Alector | Series E | 133M |
| 11/2021 | Nitrase Therapeutics | Series A | 0 |
| 9/2020 | Symbiome | Venture Round | 0 |
| 6/2013 | Tangible Science | Seed Round | 600k |
| 7/2015 | SiteOne Therapeutics | Venture Round | 0 |
| 1/2017 | SiteOne Therapeutics | Series B | 0 |
| 4/2014 | Principia Biopharma | Series B | 50M |
| 5/2013 | Effector Therapeutics | Series A | 45M |
| 1/2017 | Pionyr Immunotherapeutics | Series A | 8M |
| 4/2018 | GraphWear Technologies | Series A | 0 |
| 6/2017 | Vivace Therapeutics | Series B | 25M |
| 3/2018 | ViewPoint Therapeutics | Series B | 0 |
| 11/2015 | Atreca | Series A | 56M |
| 11/2021 | Nitrase Therapeutics | Series A | 0 |
| 7/2021 | Nobell Foods | Series B | 0 |
| 9/2020 | Symbiome | Venture Round | 0 |
| 4/2020 | Nitrase Therapeutics | Series A | 0 |
| 8/2019 | Glycomine | Series B | 0 |
| 7/2018 | Alector | Series E | 0 |
| 4/2018 | GraphWear Technologies | Series A | 0 |
| 3/2018 | Wildtype | Seed Round | 0 |
| 3/2018 | ViewPoint Therapeutics | Series B | 0 |
| 12/2017 | Pionyr Immunotherapeutics | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
